New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2014
07:06 EDTMUMicron expected to miss Q2 Street revenues but beat EPS, says Credit Suisse
Credit Suisse expects Micron to miss Q2 Street revenue estimates but beat Street earnings estimates driven by DRAM gross margin expansion. Shares are Outperform rated with a $30 price target.
News For MU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent MU news | >>
March 3, 2015
16:23 EDTMUOn The Fly: Closing Wrap
Stocks on Wall Street were lower, as the major averages receded from record levels. The Dow and S&P 500 closed yesterday at all-time highs, though the market was unable to build upon those records. Auto sales for February included disappointments for several companies, but that was quickly blamed on the poor weather during the month. With the economic calendar light, investors began looking forward to end of the week, when the highly anticipated monthly nonfarm payrolls are released. ECONOMIC EVENTS: In the U.S., no major economic data was reported. COMPANY NEWS: Automakers reported on their sales in the U.S. during February, with several falling short of expectations. Ford (F) reported sales fell about 2% last month compared to the prior year, and its stock fell 40c, or 2.41%, to $16.17 afterward. Shares of Fiat Chrysler (FCAU), which reported a 6% increase in U.S. sales last month, declined 52c, or 3.28%, to $15.31. General Motors (GM) reported its February U.S. sales rose a bit over 4%, but that was below the nearly 6% increase that had been forecast by analysts, and shares gained 19c, or 0.51%, to $37.80... Target (TGT) shares gained 32c, or 0.41%, to $78.00 as the company held its investor day meeting. During the meeting, the retailer guided for its fiscal 2015 EPS to be $4.45-$4.65, versus consensus $4.50, and projected that its sales will grow 2%-3% during the fiscal year. Target also said it is targeting $2B in share repurchases this year and said it expects 5%-10% annual dividend growth. MAJOR MOVERS: Among the notable gainers was Orexigen (OREX), which surged $1.85, or 31.95%, to $7.64 after the company disclosed that its weight loss drug, Contrave, demonstrated a statistically significant benefit over placebo for cardiovascular events when announcing a method of treatment patent was issued by the USPTO. Also higher was Springleaf Holdings (LEAF), which gained $12.19, or 32.05%, to $50.23 after agreeing to acquire OneMain Financial from Citigroup (C) for $4.25B. Among the noteworthy losers was Primoris Services (PRIM), which fell $3.87, or 18.35%, to $17.22 after reporting fourth quarter results that fell short of consensus expectations and were below last year’s fourth quarter. Also lower were shares of Micron (MU), which fell $1.58, or 5.06%, to $29.66 after Nomura downgraded the stock to Neutral from Buy. INDEXES: The Dow fell 85.26, or 0.47%, to 18,203.37, the Nasdaq lost 28.20, or 0.56%, to 4,979.90, and the S&P 500 declined 9.61, or 0.45%, to 2,107.78.
10:01 EDTMUOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:07 EDTMUMicron downgraded at Nomura
As previously reported, Nomura downgraded Micron to Neutral from Buy. The firm is forecasting bit growth to exceed the market for the second year in a row and said Micron is undershipping demand in DRAM, as technology migrations limit supply output. Nomura believes Micron is behind in technology transitions and is expected to have a big 2016 investment year in order to increase DRAM capacity and migrate technology to NAND. Nomura's analyst said May consensus estimates are too high given continued PC weakness and the shift to mobile doesn't seem factored into current expectations. Nomura lowered Micron's May earnings estimate to 73c from 80c, FY15 estimate to $3.35 from $3.65 and FY16 estimate to $4.00 from $4.85.
06:45 EDTMUMicron downgraded to Neutral from Buy at Nomura
March 2, 2015
10:27 EDTMUStocks with call strike movement; MU SYY
Micron (MU) July 37 call option implied volatility increased 18% to 39, Sysco (SYY) April 43 call option implied volatility increased 10% to 42 according to IVolatility.
07:57 EDTMUMicron DRAM pricing in-line, says Pacific Crest
After traveling with Micron's management, Pacific Crest says that the company's DRAM pricing trends are in-line with expectations and stable. The firm expects the company's DRAM margins to expand beginning in the second half of 2015 and into 2016. It continues to recommend buying the stock.
February 26, 2015
09:00 EDTMUMicron management to meet with Deutsche Bank
Meeting to be held in Boston on February 26 hosted by Deutsche Bank.
February 25, 2015
07:56 EDTMUMicron management to meet with Deutsche Bank
Subscribe for More Information
February 24, 2015
14:35 EDTMUMicron retreats amid pricing, Apple worries but analysts defend shares
Subscribe for More Information
12:42 EDTMUOn The Fly: Midday Wrap
Subscribe for More Information
12:26 EDTMUMicron weakness a buying opportunity, says Sterne Agee
Subscribe for More Information
12:15 EDTMUMicron sell-off 'totally unwarranted,' says Summit Research
Subscribe for More Information
11:48 EDTMUMicron says not seeing pricing decline alluded to in 'boutique firm' report
Subscribe for More Information
11:40 EDTMUStocks with call strike movement; MU EBAY
Subscribe for More Information
11:38 EDTMUMicron pullback a buying opportunity, says JPMorgan
Subscribe for More Information
10:43 EDTMUMicron drop on Apple speculation presents buying opportunity, says Stifel
Subscribe for More Information
09:46 EDTMUMicron falls sharply, levels to watch
Subscribe for More Information
09:46 EDTMUMicron's May guidance looks increasingly challenged, says Cleveland Research
Subscribe for More Information
February 23, 2015
10:38 EDTMUMicron management to meet with Pacific Crest
Subscribe for More Information
February 18, 2015
08:19 EDTMUMicron profitability can improve meaningfully, says Bernstein
Subscribe for More Information
1 | 2 | all recent MU news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use